Bioactive Glass Composition for Continuous Fiber Fabrication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioactive glass compositions face limitations in viscous flow sintering due to devitrification and reduced bioactivity, making it difficult to produce complex shapes and continuous fibers, which restricts their biomedical applications.
Innovation Solution
A silicate-based glass composition with specific oxide ratios, including 60-70 wt.% SiO2, 5-10 wt.% P2O5, 20-30 wt.% Na2O, and 1-10 wt.% K2O, with controlled viscosity and liquidus temperature, is developed to enable the production of continuous glass fibers and fabrics suitable for biomedical applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional bioactive glass compositions (e.g., 45S5, 13-93) are used, then bioactivity is achieved, but viscous flow sintering is limited due to devitrification and high liquidus viscosity
Solution Approach 1:
The patent modifies the chemical composition parameters of the glass, specifically adjusting the ratios of network formers (SiO2, P2O5), network modifiers (Na2O, K2O, CaO, MgO), and adding specific oxides (Al2O3, ZnO, B2O3, Li2O) to achieve optimal viscosity and bioactivity balance. This compositional parameter optimization enables the glass to maintain appropriate viscosity for sintering while preserving bioactive properties
Solution Approach 2:
The invention creates a composite glass system that combines multiple oxide components with synergistic effects. The specific combination of traditional bioactive glass formers with additional oxides (particularly Al2O3, ZnO, and B2O3) produces a composite material that simultaneously achieves low liquidus viscosity for easy sintering and high bioactivity for medical applications
2Ease of manufacture
If glass composition is optimized for low liquidus viscosity to enable fiber production, then continuous fiber fabrication becomes feasible, but bioactivity may be reduced
Solution Approach 1:
The patent carefully balances the composition parameters to achieve liquidus viscosity in the range of 100-1000 poise at processing temperatures, which is optimal for fiber drawing. Simultaneously, the composition maintains sufficient bioactive oxide content (CaO, P2O5, SiO2) to ensure hydroxyapatite formation and osteogenic activity. The specific ratio optimization allows both fiber manufacturability and bioactivity requirements to be satisfied
3Shape
If glass composition is optimized for viscous flow sintering, then complex shapes can be produced, but devitrification limits the sintering process
Solution Approach 1:
The patent optimizes the glass composition to achieve a narrow but sufficient processing window between the glass transition temperature and the devitrification temperature. By adjusting the oxide ratios, particularly adding Al2O3 and B2O3 which raise the devitrification temperature while maintaining low liquidus viscosity, the patent expands the practical sintering window enabling complex shape fabrication without crystallization
Solution Approach 2:
The invention performs preliminary compositional design to pre-establish a glass formulation that inherently resists devitrification during the sintering process. The specific oxide composition is designed beforehand to maintain glassy state stability at sintering temperatures, allowing sufficient time for viscous flow to form complex shapes before devitrification can occur
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new glass composition achieves high viscosity and bioactivity, allowing for the production of continuous fibers and fabrics that can form complex shapes and promote tissue regeneration, wound healing, and vascularization.
Implementation Method 1
currently available glasses often suffer from a lack of viscous flow sintering due to devitrification (i.e., crystallization)
Implementation Method 2
the glass composition, further comprises: hydroxyapatite formation within seven days of immersion in simulated body fluid (SBF)
Data Source
Figure 1
AI summary
A silicate-based glass composition includes: 50-70 wt.% SiO2, 0.01-10 wt.% P2O5, 10-30 wt.% NazO, 0.01-10 wt.% CaO, 0.01-10 wt.% MO, and 15-30 wt.% R2O, such that MO is the sum of MgO, CaO, SrO, BeO, and BaO, and R2O is the sum of Na2O, K2O, Li2O, Rb2O, and Cs2O.